TRIACIN-C Drug Patent Profile
✉ Email this page to a colleague
When do Triacin-c patents expire, and what generic alternatives are available?
Triacin-c is a drug marketed by Anima and is included in one NDA.
The generic ingredient in TRIACIN-C is codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride. There are nineteen drug master file entries for this compound. Additional details are available on the codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIACIN-C?
- What are the global sales for TRIACIN-C?
- What is Average Wholesale Price for TRIACIN-C?
Summary for TRIACIN-C
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | TRIACIN-C at DailyMed |
US Patents and Regulatory Information for TRIACIN-C
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anima | TRIACIN-C | codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride | SYRUP;ORAL | 088704-001 | Mar 22, 1985 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |